Little more than a year ago Commerzbank was the sick man of European finance, seemingly destined to a lonely, perhaps terminal, decline. Now insiders say the surprise acquisition of Eurohypo has given the merged firm, and its investment bank, a new lease of life. Philip Moore reports on the patient’s progress.
Philip Moore,
February 27, 2007